Tetra Bio-Pharma (TBP.T) announced they are accelerating their PLENITUDE Phase II clinical trial, which is studying QIXLEEF. QIXLEEF is Tetra’s proprietary drug formulation which contains THC and CBD and…
Research
“Psilocybin offers a potential solution to manage moderate to severe cases of TBI,” stated RVV, “Psilocybin has the potential with its neuroreparative effect to improve loss of cognitive function…
InMed Pharmaceutical’s (IN.T) IntegraSyn™ cannabinoid manufacturing approach has achieved a level of 2 grams per liter (g/L), marking a significant milestone for the commercialization of IntegraSyn™. “We are very…
Khiron Life Sciences (KHRN.V) has received its UK Continuing Professional Development (CPD) accreditation for Khiron Academy, the Company’s global medical cannabis education platform. “Over the last year, Khiron has…
If the LOI becomes a binding contract, Pure Extracts will contribute “a mix of equipment and cash to the venture”, which will allow the partners to rapidly scale-up to…
Nextleaf solutions (OILS.C) has announced the commencement of its human trails for its cannabis vapes. “The amended Cannabis Research Licence allows Nextleaf to rapidly formulate a wide variety of…
Delic Holdings (DELC.C) announced that it has acquired Complex Biotech Discovery Ventures (CBDV). “CBDV has shown they have the foresight to see what is needed in industries before it…
RAMM Pharma (RAMM.C) has begun its clinical trials studying the efficacy of its proprietary NettaVet pet cannabinoid formulation for the treatment of four pathologies in animals. “We are, from…
News this week that Canntab Therapeutics (PILL.C) received an Australian patent for their hard-pressed cannabis pill tech, to match those received earlier in North America, didn’t launch the stock…
Khiron (KHRN.V) is now the first Colombian medical cannabis company to export live cannabis clones to Europe. “Our experience in Colombia and Europe tells us that doctors require solid…